These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22727972)

  • 1. Pantoprazole significantly interferes with antiplatelet effect of clopidogrel: results of a pilot randomized trial.
    Parri MS; Gianetti J; Dushpanova A; Della Pina F; Saracini C; Marcucci R; Giusti B; Berti S
    Int J Cardiol; 2013 Sep; 167(5):2177-81. PubMed ID: 22727972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
    Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
    J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays.
    Tsantes AE; Ikonomidis I; Papadakis I; Bonovas S; Gialeraki A; Kottaridi C; Kyriakou E; Kokori S; Douramani P; Kopterides P; Karakitsos P; Lekakis J; Kapsimali V
    Thromb Res; 2013 Aug; 132(2):e105-11. PubMed ID: 23830212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
    Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL
    J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
    Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea.
    Choi YJ; Kim N; Jang IJ; Cho JY; Nam RH; Park JH; Jo HJ; Yoon H; Shin CM; Park YS; Lee DH; Jung HC
    Gut Liver; 2017 Jul; 11(4):504-511. PubMed ID: 28395507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.
    Neubauer H; Engelhardt A; Krüger JC; Lask S; Börgel J; Mügge A; Endres HG
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):91-7. PubMed ID: 20410834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
    Mizia-Stec K; Haberka M; Mizia M; Lasota B; Kunecki M; Gieszczyk K; Chmiel A; Najda J; Kyrcz-Krzemień S; Gąsior Z
    Pharmacol Rep; 2012; 64(2):360-8. PubMed ID: 22661187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of clopidogrel and acetylsalicylic acid resistance in patients with acute myocardial infarction and pantoprazole treatment in everyday practice.
    Brendel K; Weigel G; Griesmacher A; Pachinger O; Mair J
    Int J Cardiol; 2013 Sep; 168(1):589-90. PubMed ID: 23484738
    [No Abstract]   [Full Text] [Related]  

  • 12. Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.
    Kasprzak M; Koziński M; Bielis L; Boinska J; Plazuk W; Marciniak A; Budzyński J; Siller-Matula J; Rość D; Kubica J
    Cardiol J; 2009; 16(6):535-44. PubMed ID: 19950090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of C3435T multidrug resistance gene-1 (MDR-1) polymorphism on platelet reactivity and prognosis in patients with acute coronary syndromes.
    Spiewak M; Małek ŁA; Kostrzewa G; Kisiel B; Serafin A; Filipiak KJ; Płoski R; Opolski G
    Kardiol Pol; 2009 Aug; 67(8):827-34. PubMed ID: 19784880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Pantoprazole Affect the On-Treatment Platelet Reactivity in Patients With Acute STEMI Treated With ADP Receptor Blockers?-A Pilot Prospective Study.
    Bolek T; Samoš M; Šimonová R; Kovář F; Fedor M; Galajda P; Staško J; Kubisz P; Mokáň M
    Am J Ther; 2017; 24(2):e162-e166. PubMed ID: 27415979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment.
    Becatti M; Fiorillo C; Gori AM; Marcucci R; Paniccia R; Giusti B; Violi F; Pignatelli P; Gensini GF; Abbate R
    Atherosclerosis; 2013 Dec; 231(2):392-400. PubMed ID: 24267257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.
    Siller-Matula JM; Spiel AO; Lang IM; Kreiner G; Christ G; Jilma B
    Am Heart J; 2009 Jan; 157(1):148.e1-5. PubMed ID: 19081411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.
    Angiolillo DJ; Gibson CM; Cheng S; Ollier C; Nicolas O; Bergougnan L; Perrin L; LaCreta FP; Hurbin F; Dubar M
    Clin Pharmacol Ther; 2011 Jan; 89(1):65-74. PubMed ID: 20844485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
    Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA
    Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers.
    Wu J; Jia LT; Shao LM; Chen JM; Zhong DD; Xu S; Cai JT
    Eur J Clin Pharmacol; 2013 Feb; 69(2):179-87. PubMed ID: 22706585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.